Harvard Lauds NASENI-Troment Factory for Malaria Eradication

Harvard University praised the launch of the NASENI-Troment Biotechnolog factory, which aims to combat malaria and other infectious diseases in Nigeria and Africa. The factory, established through a strategic partnership with the National Agency for Science and Engineering Infrastructure (NASENI), is designed to produce 600 million diagnostic kits annually, including tests for malaria, hepatitis B and C, HIV, pregnancy, COVID-19, typhoid, syphilis, and blood glucose.

Mr. Selim Hani, Chief Executive Officer and co-founder of NASENI-Troment Biotechnolog, emphasized the factory's role in strengthening Nigeria's healthcare sovereignty by providing locally manufactured diagnostic technologies.

The facility, built over the last 18 months, aims to reduce Nigeria's reliance on imported medical diagnostics and improve access to affordable healthcare across the African region. Dr.

Engin Narinc, a technical partner, noted that this factory represents Africa's first fully localized rapid diagnostic test kit production. Prof.

Dyann Wirth from Harvard, a leading malariologist, led a team to tour the factory, expressing admiration for its potential impact on public health.